Antiphospholipid Syndrome in Systemic Autoimmune Diseases by Ronald AshersonAntiphospholipid Syndrome in Systemic Autoimmune Diseases by Ronald Asherson

Antiphospholipid Syndrome in Systemic Autoimmune Diseases

byRonald Asherson, R. Cervera, Joan Carles Reverter...

Other | April 1, 2009

Pricing and Purchase Info

$199.19 online 
$249.00 list price save 20%
Earn 996 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy and memory loss and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, from psychiatry to orthopedics.

This book provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved as well as clinical manifestations in both “the thrombotic and “non-thrombotic manifestations of this important disease.

* Comprehensive review of this major disease
* Includes information on treatment options available
Title:Antiphospholipid Syndrome in Systemic Autoimmune DiseasesFormat:OtherDimensions:266 pages, 1 × 1 × 1 inPublished:April 1, 2009Publisher:Elsevier ScienceLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0080932347

ISBN - 13:9780080932347


Table of Contents

Classification and Epidemiology of the Antiphospholipid Syndrome;
Laboratory Heterogeneity of the Antiphospholipid Antibodies:
Pathogenesis of the Antiphospholipid Syndrome;
Immunogenetics of the Antiphospholipid Syndrome;
Systemic Manifestations of the Antiphospholipid Syndrome;
Obstetric Manifestations of the Antiphospholipid Syndrome;
Antiphospholipid Antibodies and Infections and Drugs;
Antiphospholipid Antibodies and Malignancies;
Antiphospholipid Antibodies and Vascular Disorders (Atheromatosis and Vasculitis);
Treatment of the Antiphospholipid Syndrome;
Difficult situations in the Antiphospholipid Syndrome;